Analyst consensus rating
Arcturus Therapeutics Holdings Analyst Rating: Strong Buy
Direct answer
Arcturus Therapeutics Holdings's consensus rating is Strong Buy.
10 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $23.80.
Forecast evidence checked October 18, 2026.
Get free Arcturus Therapeutics Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $10.34
- Average price target
- $23.80
- High price target
- $41.00
- Low price target
- $9.00
- Low target gap
- -13%
- Target upside
- +130.2%
- High target gap
- +296.5%
- Target range width
- 309.5%
- Consensus rating
- Strong Buy
- Analysts
- 10
- Evidence date
- October 18, 2026
- Valid through
- October 25, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings has a verified Strong Buy consensus. The same dataset has an average price target of $23.80.
How far are Arcturus Therapeutics Holdings's low and high targets from the recorded price?
The low target implies -13%, while the high target implies +296.5%.
How many analysts are included in Arcturus Therapeutics Holdings's consensus?
The verified consensus includes 10 analysts.
How is Arcturus Therapeutics Holdings's target upside or downside calculated?
The average target of $23.80 is divided by the recorded price of $10.34, then one is subtracted to produce +130.2%. This does not guarantee a future return.
When was Arcturus Therapeutics Holdings's analyst forecast verified?
The data was verified on 2026-10-18. The dataset is valid through 2026-10-25.